“Risperidone Versus Quetiapine: Risk of Developing Metabolic Syndromes in Patients Suffering from Psychiatry Disorders of a Health Care Center”. Asian Journal of Pharmaceutical and Health Sciences 10, no. 3 (September 30, 2020): 2309–2317. Accessed January 10, 2026. https://ajphs.com/index.php/ajphs/article/view/602.